Detail akcie China Pharma Rg online

Business Summary: China Pharma Holdings Inc is a company principally engaged in the development, manufacture, and marketing of pharmaceutical products for human use. The Company is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The Company's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The Company's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The Company mainly operates in the domestic market.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, China Pharma Holdings Inc revenues decreased 14% to $2.9M. Net loss decreased 44% to $2M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Research and development expenses decrease of 68% to $91K (expense), Selling expenses decrease of 25% to $266K (expense).